At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 62 enrolled
Drug / intervention
Nebulized 3% saline +1 moredrug
Likely dose
Nebulized 3% saline 4 mLfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Nebulized Hypertonic Saline for Acute Bronchiolitis in the Emergency Department
In Brief
A Phase 4 clinical trial evaluating Nebulized 3% saline and Nebulized 0.9% Normal Saline for Bronchiolitis, Viral and Saline Solution, Hypertonic. Completed, enrolled 62 participants across 1 site.
Detailed Summary
The purpose of this study is to determine whether nebulized 3% hypertonic saline (HS) improves respiratory distress in children 2-23 months presenting to the emergency department (ED) with acute bronchiolitis with persistent respiratory distress after initial therapy with a trial of nebulized albuterol.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBronchiolitis, Viral, Saline Solution, Hypertonic
CountriesUnited States
Collaborators--
Timeline
Phase 4CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartOct 2010
First PostedNov 2010
Primary CompletionDec 2011
TodayJul 2026
First PostedNov 24, 2010
Enrollment StartOct 1, 2010
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 15.6 years ago
Interventions
Nebulized 3% salinedrug
4 mL of nebulized 3% saline once
Nebulized 0.9% Normal Salinedrug
4 mL of 0.9% nebulized normal saline once